Exploring the relationship between BI 456906 exposure and change in fasting plasma glucose, fasting serum insulin, and glycated hemoglobin (HbA1c) using population PKPD modeling

ACoP14 (Nov 2023), Poster: M-017
Mc Laughlin AM, Retlich S, Wojtyniak JG, Bergstrand M, Ooi QX, Smania G.
ConferenceEndocrinologyMetabolismObesityPharmacometrics

This poster dissects the direct and indirect effects of survodutide, a dual glucagon and GLP1 receptor agonist, on metabolic markers in patients with type 2 diabetes mellitus.

Pharmetheus Affiliates

Portrait-of-Anna-Mc-Laughlin_Pharmetheus
Senior Director, MIDD Consultant

Anna Mc Laughlin

See bio
Portrait-of-Martin-Bergstrand_Pharmetheus
Principal Director, MIDD Scientific Lead

Martin Bergstrand

See bio
Portrait-of-Qing-Xi-Ooi-Pharmetheus
Senior Director, MIDD Consultant

Qing Xi Ooi

See bio
Portrait-of-Giovanni-Smania-Pharmetheus
Principal Director, MIDD Consultant

Giovanni Smania

See bio